From: SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (years) | 1.043 | 0.75–1.132 | 0.288 | |||
Gender | 1.142 | 0.952–1.378 | 0.588 | |||
Tumour Location | 1.024 | 0.944–1.389 | 0.52 | |||
Lymph node metastasis | 1.336 | 1.045–1.092 | 0.024* | 1.522 | 0.452–5.124 | 0.472 |
Positive lymph node ratio | 2.584 | 1.267–7.321 | <0.001* | 2.612 | 1.214–5.622 | 0.014* |
Pathological type | 1.018 | 0.694–1.258 | 0.474 | |||
Pathological grade | 2.094 | 1.316–4.167 | 0.004* | 0.474 | 0.153–1.464 | 0.194 |
Tumour size | 1.921 | 1.156–3.126 | 0.004* | 0.367 | 0.049–2.752 | 0.329 |
Tumour infiltration | 1.321 | 1.054–2.421 | 0.003* | 1.524 | 0.953–2.439 | 0.079 |
AJCC staging | 2.126 | 1.335–6.075 | <0.001* | 1.615 | 0.735–3.547 | 0.233 |
Adjacent-to-GC tissue-SSH1 | 1.164 | 0.925–1.637 | 0.095 | |||
GC tissue-SSH1 | 1.564 | 1.109–2.352 | 0.016* | 1.787 | 1.056–3.021 | 0.030* |